Results 191 to 200 of about 19,855 (219)
Some of the next articles are maybe not open access.

A Child with Serious Chikungunya Virus (CHIKV) Infection Requiring Intensive Care, After an Outbreak

The Indian Journal of Pediatrics, 2010
A 5 1/2-yr-old boy presented with high grade fever for 4 days, and cervical adenitis, body ache, arthralgia, followed by sudden onset of breathlessness. He had clinical, electrocardiographic and echo evidence of myocarditis and congestive cardiac failure.
P Ramesh, Menon   +4 more
openaire   +2 more sources

Vathasura Kudineer, an Andrographis based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under in vitro conditions

Journal of Ethnopharmacology, 2023
Chikungunya disease (CHIKD) is caused by the alphavirus, chikungunya virus (CHIKV) and is characterized by acute fever and joint inflammation; the inflammation continues even after clearance of the virus from the system, persisting for several months to years. Currently, there are no modern medicines/vaccines available for its treatment and use of over-
Abdul Hasan   +6 more
openaire   +2 more sources

Antibodies against chikungunya virus structural proteins reveal the presence of CHIKV virions in migrasomes

Journal of Immunological Methods
Chikungunya fever (CHIKF) is a viral illness transmitted by mosquitoes, caused by the chikungunya virus (CHIKV), which has led to millions of infections globally. Antibodies against CHIKV serve as essential tools for research on this virus. In this study, we designed peptides corresponding to the E1, E2, E3, and capsid proteins of CHIKV to immunize New
Shengnan, Wang   +4 more
openaire   +2 more sources

Proteomic profiling of chikungunya virus-infected human muscle cells: Reveal the role of cytoskeleton network in CHIKV replication

Journal of Proteomics, 2014
Chikungunya virus (CHIKV) is an arthropod-borne, positive-sense, single-stranded RNA virus belonging to genus Alphavirus and family Togaviridae. The clinical manifestations developed upon CHIKV-infection include fever, myositis, arthralgia and maculopapular rash. Thus, the re-emergence of CHIKV has posed serious health threats worldwide.
Too Horng Khit, Issac   +2 more
openaire   +2 more sources

Mathematical modelling of within-host Chikungunya virus dynamics with adaptive immune response

Modeling Earth Systems and Environment, 2023
T. Alade   +3 more
semanticscholar   +1 more source

Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns

Nature Medicine
The first vaccine against chikungunya virus (CHIKV) has now been licensed; however, due to a limited knowledge of the underlying global burden, its potential to reduce disease burden remains unknown.
Gabriel Ribeiro dos Santos   +15 more
semanticscholar   +1 more source

Cervical cancer prevention and control in women living with human immunodeficiency virus

Ca-A Cancer Journal for Clinicians, 2021
Philip E Castle, Vikrant V Sahasrabuddhe
exaly  

EPH160 Burden of Illness (BOI) and Paucity of Treatment of the Mosquito-Borne Chikungunya Virus (CHIKV)

Value in Health, 2022
K Bakker   +4 more
openaire   +1 more source

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Epstein–Barr virus and multiple sclerosis

Nature Reviews Microbiology, 2022
Samantha S Soldan, Paul M Lieberman
exaly  

Home - About - Disclaimer - Privacy